Sonalee Agarwal is the VP, Value & Evidence Strategy at Alnylam Pharmaceuticals. She is a leader in commercial, medical, and market access strategy and brings with her more than 15 years of experience in pharma and biotech. Over the 15 years, she had worked on many products with launches in multiple global markets with particular focus on commercial strategy, market access, pricing and reimbursement strategy, market entry models, and early product commercialization across broad range of complex therapeutic areas: Orphans diseases Neuroscience, Oncology, and Cardiovascular Disease. Prior to Alnylam, she worked at Biogen where she led a team working on multiple sclerosis, Spinraza, and pipeline Alzheimer’s and immunology assets. She holds a Ph.D. degree from University of Texas at Austin and a B.Pharm from University of Mumbai.